Companies: 10,795·Total market cap: $144.5T
ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

SPRYNASDAQHealthcare● Active
$8.99
+$0.43(+5.02%)
Market Cap$892736325
P/E Ratio
52W High$18.9
52W Low$6.66

ARS Pharmaceuticals, Inc. (SPRY) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · SPRY · as of Mar 9, 2026

Latest filing snapshot

158
+3+1.94%vs prior year

ARS Pharmaceuticals, Inc. (SPRY) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
158
Change (1Y)
+3
Growth % (1Y)
+1.94%
Revenue / Employee
$533.4K
Net Income / Employee
$-1.08M
Market Cap
$893M

SPRY Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-09158+3+1.94%
2025-03-20155+131+545.83%
2024-03-2124+7+41.18%
2023-03-2317-73-81.11%
2022-03-3190

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
ProKidney Corp.
PROK
ProKidney Corp.
204
#2
Kura Oncology, Inc.
KURA
Kura Oncology, Inc.
192
#3
ARS Pharmaceuticals, Inc.
SPRY
ARS Pharmaceuticals, Inc.YOU
158
#4
Nanobiotix S.A.
NBTX
Nanobiotix S.A.
108
#5
GH Research PLC
GHRS
GH Research PLC
50
#6
Arbutus Biopharma Corporation
ABUS
Arbutus Biopharma Corporation
44
#7
LENZ Therapeutics, Inc.
LENZ
LENZ Therapeutics, Inc.
6
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · SPRY peer comparison

About SPRY employees

SPRY Employees · Headcount

ARS Pharmaceuticals, Inc. (SPRY) employee data is sourced from the annual SEC 10-K filing. As of 2025, ARS Pharmaceuticals, Inc. had 158 full-time employees globally. Full-time employees only. Global consolidated headcount.

ARS Pharmaceuticals, Inc. employs 158 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $533,405, reflecting the company's operational efficiency.

ARS Pharmaceuticals, Inc.'s workforce increased by 3 (1.94%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

ARS Pharmaceuticals, Inc.'s revenue per employee of $533,405 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

SPRY Employees · 5 questions

As of the latest SEC 10-K filing (2025), ARS Pharmaceuticals, Inc. had 158 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

ARS Pharmaceuticals, Inc. employee counthow many employees does ARS Pharmaceuticals, Inc. haveSPRY total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-09